FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W4210936110> ?p ?o ?g. }

• W4210936110 endingPage "8" @default.
• W4210936110 startingPage "1" @default.
• W4210936110 abstract "We have proposed an effective mechanism to corroborate the efficacy of microwave ablation (MA) in the treatment of stage I renal clear cell carcinoma in this paper. For this purpose, a total of 96 patients with stage I renal clear cell carcinoma presented in our hospital from May 2018 to January 2021 were randomly divided into CT group (n = 48) and MRI group (n = 48). Patients in both groups were treated with microwave ablation after pathological diagnosis. Patients in the CT group received enhanced CT examination to monitor the therapeutic effect; in contrast, patients in the MRI group received MRI examination to monitor their therapeutic effect. The focus areas before and after tumor microwave ablation were compared between the two groups. The patients were followed up to 1 year after the operation, and the microwave ablation inactivation rates of the two groups were compared according to the postoperative follow-up results. There was no significant difference between CT and MRI in the levels of long and short diameter before and after microwave ablation of renal clear cell carcinoma (P > 0.05). In the CT group, CT examination was performed within 24 hours after microwave ablation treatment, and 44 of 48 ablation lesions showed complete ablation. The remaining 4 lesions showed nodular heterogeneous enhancement in the arterial phase, indicating that the tumor remained. Microwave ablation was performed on the residual lesions during the operation, and then enhanced CT was performed again to show that the lesions were ablated completely. In the MRI group, MRI examination was performed within 24 hours after microwave ablation treatment, and 45 of 48 ablation lesions showed complete ablation. The remaining 3 lesions showed nodular heterogeneous enhancement in the arterial phase, indicating that the tumor remained. Microwave ablation was performed on the residual lesions during the operation, and MRI examination showed that the lesions were ablated completely. The patients were followed up to 1 year after the operation, and the microwave ablation inactivation rate of the two groups was compared according to the postoperative follow-up results as the gold standard. The inactivation rate of microwave ablation in the CT group was 89.58 (43/48). The inactivation rate of microwave ablation in the MRI group was 100.00% (48/48). The inactivation rate of microwave ablation in the MRI group was higher than that in the CT group (χ2 = 5.275, P = 0.021)." @default.
• W4210936110 created "2022-02-09" @default.
• W4210936110 creator A5025104771 @default.
• W4210936110 creator A5025326285 @default.
• W4210936110 creator A5053079613 @default.
• W4210936110 creator A5067835324 @default.
• W4210936110 creator A5072807699 @default.
• W4210936110 creator A5085176892 @default.
• W4210936110 date "2022-02-07" @default.
• W4210936110 modified "2023-09-25" @default.
• W4210936110 title "Clinical Study on the Efficacy of Microwave Ablation (MA) in the Treatment of Stage I Renal Clear Cell Carcinoma by CT and MRI Imaging" @default.
• W4210936110 cites W2010762033 @default.
• W4210936110 cites W2015545710 @default.
• W4210936110 cites W2558951764 @default.
• W4210936110 cites W2746752449 @default.
• W4210936110 cites W2772333773 @default.
• W4210936110 cites W2884170377 @default.
• W4210936110 cites W2889715958 @default.
• W4210936110 cites W2890321787 @default.
• W4210936110 cites W2898109757 @default.
• W4210936110 cites W2902704467 @default.
• W4210936110 cites W2903654239 @default.
• W4210936110 cites W2945220204 @default.
• W4210936110 cites W2972294778 @default.
• W4210936110 cites W2973313458 @default.
• W4210936110 cites W3004306740 @default.
• W4210936110 cites W3006192056 @default.
• W4210936110 cites W3009766522 @default.
• W4210936110 cites W3022250436 @default.
• W4210936110 cites W3039781805 @default.
• W4210936110 cites W3039871351 @default.
• W4210936110 cites W3044459959 @default.
• W4210936110 cites W3101198680 @default.
• W4210936110 cites W3138760845 @default.
• W4210936110 cites W3208866396 @default.
• W4210936110 cites W3215692897 @default.
• W4210936110 doi "https://doi.org/10.1155/2022/8446294" @default.
• W4210936110 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/35178237" @default.
• W4210936110 hasPublicationYear "2022" @default.
• W4210936110 type Work @default.
• W4210936110 citedByCount "1" @default.
• W4210936110 countsByYear W42109361102023 @default.
• W4210936110 crossrefType "journal-article" @default.
• W4210936110 hasAuthorship W4210936110A5025104771 @default.
• W4210936110 hasAuthorship W4210936110A5025326285 @default.
• W4210936110 hasAuthorship W4210936110A5053079613 @default.
• W4210936110 hasAuthorship W4210936110A5067835324 @default.
• W4210936110 hasAuthorship W4210936110A5072807699 @default.
• W4210936110 hasAuthorship W4210936110A5085176892 @default.
• W4210936110 hasBestOaLocation W42109361101 @default.
• W4210936110 hasConcept C102652120 @default.
• W4210936110 hasConcept C126322002 @default.
• W4210936110 hasConcept C126838900 @default.
• W4210936110 hasConcept C141071460 @default.
• W4210936110 hasConcept C142724271 @default.
• W4210936110 hasConcept C143409427 @default.
• W4210936110 hasConcept C146357865 @default.
• W4210936110 hasConcept C151730666 @default.
• W4210936110 hasConcept C207886595 @default.
• W4210936110 hasConcept C2777472916 @default.
• W4210936110 hasConcept C2777546739 @default.
• W4210936110 hasConcept C2778014663 @default.
• W4210936110 hasConcept C2778902805 @default.
• W4210936110 hasConcept C2989005 @default.
• W4210936110 hasConcept C71924100 @default.
• W4210936110 hasConcept C86803240 @default.
• W4210936110 hasConceptScore W4210936110C102652120 @default.
• W4210936110 hasConceptScore W4210936110C126322002 @default.
• W4210936110 hasConceptScore W4210936110C126838900 @default.
• W4210936110 hasConceptScore W4210936110C141071460 @default.
• W4210936110 hasConceptScore W4210936110C142724271 @default.
• W4210936110 hasConceptScore W4210936110C143409427 @default.
• W4210936110 hasConceptScore W4210936110C146357865 @default.
• W4210936110 hasConceptScore W4210936110C151730666 @default.
• W4210936110 hasConceptScore W4210936110C207886595 @default.
• W4210936110 hasConceptScore W4210936110C2777472916 @default.
• W4210936110 hasConceptScore W4210936110C2777546739 @default.
• W4210936110 hasConceptScore W4210936110C2778014663 @default.
• W4210936110 hasConceptScore W4210936110C2778902805 @default.
• W4210936110 hasConceptScore W4210936110C2989005 @default.
• W4210936110 hasConceptScore W4210936110C71924100 @default.
• W4210936110 hasConceptScore W4210936110C86803240 @default.
• W4210936110 hasLocation W42109361101 @default.
• W4210936110 hasLocation W42109361102 @default.
• W4210936110 hasLocation W42109361103 @default.
• W4210936110 hasLocation W42109361104 @default.
• W4210936110 hasOpenAccess W4210936110 @default.
• W4210936110 hasPrimaryLocation W42109361101 @default.
• W4210936110 hasRelatedWork W1968786290 @default.
• W4210936110 hasRelatedWork W1980944509 @default.
• W4210936110 hasRelatedWork W1981591254 @default.
• W4210936110 hasRelatedWork W2016336310 @default.
• W4210936110 hasRelatedWork W2093993648 @default.
• W4210936110 hasRelatedWork W2105335598 @default.
• W4210936110 hasRelatedWork W2107103020 @default.
• W4210936110 hasRelatedWork W2384147689 @default.
• W4210936110 hasRelatedWork W3025118876 @default.
• W4210936110 hasRelatedWork W3157154227 @default.

• next